.png)
Douglas Rissing
- The U.S. Supreme Court has refused to hear an appeal filed by Merck (NYSE:MRK) that attempted to block a large lawsuit from hundreds of women who argue that the company's osteoporosis drug Fosamax (alendronate) led to the development of atypical thighbone
English (US) ·